Risdiplam 750micrograms/ml oral solution sugar free
NHS hospitals in England used £113,693,838 of indicative cost of Risdiplam 750micrograms/ml oral solution sugar free in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is down 11.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Risdiplam 750micrograms/ml oral solution sugar free: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Risdiplam 750micrograms/ml oral solution sugar free most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £9,732,800 |
| University College London Foundation Tr | £9,693,300 |
| Oxford University Hospitals Nhs Ft | £8,437,200 |
| University Hospital Southampton Nhs Ft | £6,659,700 |
| Cambridge Univ Hosp Nhs Foundation Trust | £5,601,100 |
| Salford Royal Nhs Foundation Trust | £5,506,300 |
| Guy's & St Thomas' Nhs Foundation Trust | £5,283,125 |
| Sheffield Teaching Hospitals Nhs Trust | £5,142,900 |
| Alder Hey Childrens Nhs Foundation Trust | £5,000,700 |
| Robert Jones & Agnes Hunt Hpl Nhs Trust | £4,969,100 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.